MedShape Inc. Announces Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
ATLANTA (March 15, 2012) - MedShape, Inc., the industry leader in innovative shape memory orthopedic devices, announces today that it has received preferred vendor status at Veterans Health Administration Hospitals and other federally funded hospitals for its ExoShape and Morphix product lines for soft tissue fixation.
The ExoShape device was developed with Small Business Innovation Research (SBIR) grant assistance through National Science Foundation (NSF) Grants 635620 and 750247. The Morphix device was developed with SBIR grant assistance through National Institutes of Health (NIH) Grants #1R43AR056154-01, 2R44AR056154-02, and 5R44AR056154-03.
The Small Business Act Policy Directive Section 4 (c) (7) provides that "Government owned, contractor operated facilities...give preference including sole source awards to the awardee that developed the technology." The Directive Section 4 (c) (7) also states that "the competition for SBIR Phase I and Phase II awards satisfies any competition requirement of the Armed Services Procurement Act, The Federal Property and Administrative Services Act and the Competition in Contracting Act."
"The grant support from the NIH and NSF were instrumental to the development of the unique technology that underlies our distinctive Morphix and ExoShape products. These products are textbook examples of how the SBIR program is intended to work to take novel technology from the lab to the marketplace and advance the US economy," stated Ken Gall, PhD, a leader in MedShape's technology function.
"MedShape has already enjoyed the significant advantage of preferred supplier status and sole source contracting at multiple VHA and federally funded hospitals. We are looking forward to continued success at similar hospitals as our penetration of the US market accelerates," stated Kurt Jacobus, PhD, a leader in MedShape's business function.
About MedShape, Inc.:
MedShape, Inc. is a privately held medical device company working to develop and commercialize a portfolio of surgical solutions that use its patented shape memory technologies to address the increasing demand for improved sports medicine, joint fusion and musculoskeletal trauma products. For more information, visit www.medshape.com.
ExoShape and Morphix are registered trademarks of MedShape, Inc.